StockData
PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB) stock

ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3046% below fair value
$1.58−0.01 (-0.63%)

Close on Nov 13, 2026Market cap $12.79MP/E –Yield –

PMGC statistics

63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$12.79M
$272.32M
Enterprise Value
-$6.00M
$146.23M
PS Ratio
4.96
3.66
PB Ratio
0.76
2.00
P/TBV Ratio
1.66
2.22

Enterprise valuationIndustry

EV / Sales
-2.33
2.57

Share statisticsIndustry

Shares Change (QoQ)
217.7%
0.50%
Float
4M
49M
Shares Held by Insiders
55.2%
11.7%
Shares Held by Institutions
0.33%
56.4%

Short sellingIndustry

Short Interest
18,653
–
Short Interest Change
0.73%
-0.80%
Short % of Float
0.51%
9.01%
Short % of Shares Outstanding
0.23%
6.30%
Days to Cover
2.61
5.15

Stock price statisticsIndustry

52-Week High
$1432.77
–
52-Week Low
$1.41
–
20-Day Moving Average
$2.20
–
50-Day Moving Average
$3.26
–
200-Day Moving Average
$25.36
–
Average True Range (14)
$0.27
–
Price Change (1 Week)
-1.86%
-1.15%
Price Change (1 Month)
-48.0%
-4.87%
Price Change (3 Months)
-81.9%
-21.0%
Price Change (6 Months)
-92.4%
-20.6%
Price Change (YTD)
-99.6%
-23.6%
Price Change (1 Year)
-99.9%
-22.4%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
708,240
–
Average Volume (90 Days)
248,937
–
Relative Volume
0.13
0.70
Relative Strength Index (14)
18.8
43.4
Volatility (1 Year)
239.8%
80.1%
Beta (5 Years)
1.68
1.07

MarginsIndustry

Gross Margin
31.1%
53.1%
Profit Margin
-523.0%
-31.6%

Returns on capitalIndustry

Return on Equity (ROE)
-104.6%
-49.9%
Return on Assets (ROA)
-58.7%
-40.6%

Financial positionIndustry

Current Ratio
1.36
3.30
Quick Ratio
1.25
2.39

GrowthIndustry

Revenue Growth (3Y CAGR)
-8.34%
2.25%

EfficiencyIndustry

Asset Turnover
0.11
0.40
Inventory Turnover
1.91
2.73
Revenue Per Employee
$80.58K
$429.29K
Profits Per Employee
-$421.43K
-$689.41K
Employee Count
32
74
WACC
13.5%
10.2%

Income statement (TTM)Industry

Revenue
$2.58M
$66.37M
Gross Profit
$801.48K
$120.78M
Net Income
-$13.49M
-$22.35M

Balance sheetIndustry

Net Cash (Debt)
$18.79M
$17.76M
Net Cash Per Share
$2.32
$0.80
Equity (Book Value)
$16.74M
$53.89M
Book Value Per Share
$2.07
$1.50
Tangible Book Value
$7.71M
$27.13M
Working Capital
$5.50M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$8.21M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-105.4%
-21.8%

Taxes and interestIndustry

Interest Expense
$1.30M
$2.90M

Scores and fair valueIndustry

Altman Z-Score
-0.47
0.23
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodELABS&P 500DifferenceELAB per yearS&P 500 per year
1 month-46.6%-3.0%−43.6 pts
3 months-82.4%-2.8%−79.6 pts
Year to date-99.6%+11.5%−111.0 pts
1 year-99.9%+13.5%−113.3 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ELAB shares were sold short on Oct 30, 2026, up 0.7% from the previous report, or 0.51% of the shares available to trade. At recent volumes it would take 2.6 days to buy them back. Over the last 20 sessions, 54.2% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202618,653+0.7%7,1552.6
Oct 15, 202618,518-32.9%31,1221.0
Sep 30, 202627,598-19.7%67,3491.0
Sep 15, 202634,386+35.2%31,3971.1
Aug 31, 202625,435-90.4%86,2311.0
Aug 14, 2026265,900-39.6%216,4571.2
Jul 31, 2026440,372-45.6%847,1931.0
Jul 15, 2026809,201+144.4%10,484,0441.0
Jun 30, 2026331,075-44.9%387,0771.0
Jun 15, 2026601,191+0.1%3,467,8881.0
May 29, 2026600,477+55.8%1,520,5581.0
May 15, 2026385,403+63.2%733,2001.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?